BIO-TECHNE CORP (TECH) Fundamental Analysis & Valuation
NASDAQ:TECH • US09073M1045
Current stock price
51.95 USD
-1.56 (-2.92%)
At close:
51.56 USD
-0.39 (-0.75%)
After Hours:
This TECH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. TECH Profitability Analysis
1.1 Basic Checks
- In the past year TECH was profitable.
- In the past year TECH had a positive cash flow from operations.
- In the past 5 years TECH has always been profitable.
- TECH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- TECH has a Return On Assets of 3.17%. This is in the better half of the industry: TECH outperforms 73.68% of its industry peers.
- TECH's Return On Equity of 3.98% is fine compared to the rest of the industry. TECH outperforms 73.68% of its industry peers.
- TECH has a better Return On Invested Capital (9.52%) than 89.47% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for TECH is below the industry average of 11.01%.
- The 3 year average ROIC (9.00%) for TECH is below the current ROIC(9.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROIC | 9.52% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
1.3 Margins
- Looking at the Profit Margin, with a value of 6.58%, TECH is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
- In the last couple of years the Profit Margin of TECH has declined.
- The Operating Margin of TECH (22.59%) is better than 92.98% of its industry peers.
- In the last couple of years the Operating Margin of TECH has remained more or less at the same level.
- TECH's Gross Margin of 66.60% is amongst the best of the industry. TECH outperforms 87.72% of its industry peers.
- TECH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% |
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
2. TECH Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TECH is destroying value.
- TECH has less shares outstanding than it did 1 year ago.
- The number of shares outstanding for TECH has been increased compared to 5 years ago.
- TECH has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 11.22 indicates that TECH is not in any danger for bankruptcy at the moment.
- With an excellent Altman-Z score value of 11.22, TECH belongs to the best of the industry, outperforming 96.49% of the companies in the same industry.
- The Debt to FCF ratio of TECH is 1.17, which is an excellent value as it means it would take TECH, only 1.17 years of fcf income to pay off all of its debts.
- TECH's Debt to FCF ratio of 1.17 is amongst the best of the industry. TECH outperforms 91.23% of its industry peers.
- TECH has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
- TECH has a better Debt to Equity ratio (0.13) than 63.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Altman-Z | 11.22 |
ROIC/WACC0.87
WACC10.99%
2.3 Liquidity
- A Current Ratio of 4.54 indicates that TECH has no problem at all paying its short term obligations.
- TECH's Current ratio of 4.54 is fine compared to the rest of the industry. TECH outperforms 73.68% of its industry peers.
- A Quick Ratio of 3.08 indicates that TECH has no problem at all paying its short term obligations.
- TECH has a Quick ratio of 3.08. This is in the better half of the industry: TECH outperforms 61.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 |
3. TECH Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 8.84% over the past year.
- TECH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.25% yearly.
- The Revenue has been growing slightly by 1.64% in the past year.
- TECH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.55% yearly.
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
3.2 Future
- TECH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.61% yearly.
- The Revenue is expected to grow by 7.10% on average over the next years.
EPS Next Y4.8%
EPS Next 2Y7.28%
EPS Next 3Y9.92%
EPS Next 5Y8.61%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.57%
Revenue Next 5Y7.1%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. TECH Valuation Analysis
4.1 Price/Earnings Ratio
- TECH is valuated quite expensively with a Price/Earnings ratio of 26.37.
- Compared to the rest of the industry, the Price/Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 70.18% of the companies listed in the same industry.
- TECH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
- TECH is valuated rather expensively with a Price/Forward Earnings ratio of 23.39.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 70.18% of the companies listed in the same industry.
- TECH is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.37 | ||
| Fwd PE | 23.39 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 63.16% of the companies listed in the same industry.
- TECH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TECH is cheaper than 61.40% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.44 | ||
| EV/EBITDA | 21.71 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
- TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)5.49
PEG (5Y)2.34
EPS Next 2Y7.28%
EPS Next 3Y9.92%
5. TECH Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.61%, TECH is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.11, TECH pays a better dividend. On top of this TECH pays more dividend than 92.98% of the companies listed in the same industry.
- With a Dividend Yield of 0.61, TECH pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
- The dividend of TECH has a limited annual growth rate of 0.11%.
- TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
- TECH has decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
- TECH pays out 62.38% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.38%
EPS Next 2Y7.28%
EPS Next 3Y9.92%
TECH Fundamentals: All Metrics, Ratios and Statistics
51.95
-1.56 (-2.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Industry Strength17.39
Industry Growth53.42
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-06 2026-05-06/bmo
Inst Owners113.81%
Inst Owner Change-0.07%
Ins Owners0.26%
Ins Owner Change2.73%
Market Cap8.13B
Revenue(TTM)1.22B
Net Income(TTM)79.96M
Analysts80.87
Price Target76.73 (47.7%)
Short Float %8.98%
Short Ratio6.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP62.38%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-13 2026-02-13 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.96%
Min EPS beat(2)-2.04%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)6
Avg EPS beat(8)3.61%
EPS beat(12)6
Avg EPS beat(12)1.11%
EPS beat(16)7
Avg EPS beat(16)-2.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-0.04%
Revenue beat(4)0
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)-0.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.65%
Revenue beat(12)3
Avg Revenue beat(12)-1.76%
Revenue beat(16)4
Avg Revenue beat(16)-2.17%
PT rev (1m)0%
PT rev (3m)7.39%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-4.68%
EPS NY rev (1m)-0.23%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.37 | ||
| Fwd PE | 23.39 | ||
| P/S | 6.69 | ||
| P/FCF | 36.44 | ||
| P/OCF | 32.6 | ||
| P/B | 4.04 | ||
| P/tB | 11.69 | ||
| EV/EBITDA | 21.71 |
EPS(TTM)1.97
EY3.79%
EPS(NY)2.22
Fwd EY4.28%
FCF(TTM)1.43
FCFY2.74%
OCF(TTM)1.59
OCFY3.07%
SpS7.77
BVpS12.85
TBVpS4.45
PEG (NY)5.49
PEG (5Y)2.34
Graham Number23.8694 (-54.05%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 3.98% | ||
| ROCE | 11.53% | ||
| ROIC | 9.52% | ||
| ROICexc | 10.26% | ||
| ROICexgc | 25.36% | ||
| OM | 22.59% | ||
| PM (TTM) | 6.58% | ||
| GM | 66.6% | ||
| FCFM | 18.35% |
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score8
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 1.17 | ||
| Debt/EBITDA | 0.69 | ||
| Cap/Depr | 25.35% | ||
| Cap/Sales | 2.16% | ||
| Interest Coverage | 15.32 | ||
| Cash Conversion | 65.89% | ||
| Profit Quality | 278.92% | ||
| Current Ratio | 4.54 | ||
| Quick Ratio | 3.08 | ||
| Altman-Z | 11.22 |
F-Score8
WACC10.99%
ROIC/WACC0.87
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)8.84%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%9.52%
EPS Next Y4.8%
EPS Next 2Y7.28%
EPS Next 3Y9.92%
EPS Next 5Y8.61%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%0.24%
Revenue Next Year0.73%
Revenue Next 2Y3.52%
Revenue Next 3Y5.57%
Revenue Next 5Y7.1%
EBIT growth 1Y9.53%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year16.58%
EBIT Next 3Y12.12%
EBIT Next 5Y8.56%
FCF growth 1Y-1.07%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-9.8%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%
BIO-TECHNE CORP / TECH Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?
ChartMill assigns a fundamental rating of 6 / 10 to TECH.
What is the valuation status of BIO-TECHNE CORP (TECH) stock?
ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.
Can you provide the profitability details for BIO-TECHNE CORP?
BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.
Can you provide the financial health for TECH stock?
The financial health rating of BIO-TECHNE CORP (TECH) is 8 / 10.
What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?
The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 4.8% in the next year.